Inhibikase Therapeutics Reports Preliminary FDA Meeting Outcomes for IkT-001Pro
Feb 8, 2024
Inhibikase Invest Information
Inhibikase Therapeutics Announces Q3 Financial Results and Activities Update
Nov 15, 2023